Artemether (an artemisinin derivative) suppresses hepatic gluconeogenesis in diabetic mice by activating miR-155-C/EBPβ axis
Life Sciences
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Artemether (an artemisinin derivative) suppresses hepatic gluconeogenesis in diabetic mice by activating miR-155-C/EBPβ axis. // Life Sciences. – URL: https://www.sciencedirect.com/science/article/pii/S0024320526005230?dgcid=rss_sd_all
Artemether (an artemisinin derivative) suppresses hepatic gluconeogenesis in diabetic mice by activating miR-155-C/EBPβ axis. Life Sciences. https://www.sciencedirect.com/science/article/pii/S0024320526005230?dgcid=rss_sd_all
“Artemether (an artemisinin derivative) suppresses hepatic gluconeogenesis in diabetic mice by activating miR-155-C/EBPβ axis.” Life Sciences.
@article{article9154,
title = {Artemether (an artemisinin derivative) suppresses hepatic gluconeogenesis in diabetic mice by activating miR-155-C/EBPβ axis},
journal = {Life Sciences},
url = {https://www.sciencedirect.com/science/article/pii/S0024320526005230?dgcid=rss_sd_all}
}